Netty Kinsella

ORCID: 0000-0003-3807-9503
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life
  • Renal cell carcinoma treatment
  • Urinary Bladder and Prostate Research
  • Genital Health and Disease
  • Patient-Provider Communication in Healthcare
  • Testicular diseases and treatments
  • Economic and Financial Impacts of Cancer
  • Advances in Oncology and Radiotherapy
  • Pelvic floor disorders treatments
  • Palliative Care and End-of-Life Issues
  • Cancer survivorship and care
  • Colorectal Cancer Screening and Detection
  • Advanced Radiotherapy Techniques
  • Urologic and reproductive health conditions
  • Radiation Dose and Imaging
  • Sexual function and dysfunction studies
  • COVID-19 and healthcare impacts
  • Childhood Cancer Survivors' Quality of Life
  • Patient Satisfaction in Healthcare
  • Urinary Tract Infections Management
  • Behavioral Health and Interventions

Royal Marsden NHS Foundation Trust
2016-2025

Royal Marsden Hospital
2017-2025

King's College London
2017-2024

Epsom and St Helier University Hospitals NHS Trust
2022

Mater Misericordiae University Hospital
2021

Frimley Health NHS Foundation Trust
2021

Guy's Hospital
2013-2019

London Cancer
2019

University of South Australia
2018

Guy's and St Thomas' NHS Foundation Trust
2010-2016

Active surveillance (AS) is recommended for low-risk and some intermediate-risk prostate cancer. Uptake practice of AS vary significantly across different settings, as does the experience surveillance-from which tests are offered, to levels psychological support.To explore current best determine most important research priorities in cancer.A formal consensus process was followed, with an international expert panel purposively sampled participants a range health care professionals...

10.1016/j.euo.2023.01.003 article EN cc-by European Urology Oncology 2023-01-28

To describe a protocol for transperineal sector biopsies (TPSB) of the prostate and present clinical experience this technique in UK population.A retrospective review single-centre TPSB approach was undertaken that preferentially, but not exclusively, targeted peripheral zone with 24-38 cores using 'sector plan'. Procedures were carried out under general anaesthetic most patients. Between January 2007 August 2011, 634 consecutive patients underwent following indications: prior negative...

10.1111/bju.12282 article EN BJU International 2013-06-13

Objective To explore patients’ experience of decision making regarding treatment localised kidney cancer. Methods A total 21 patients with cancer, across three countries, participated in either four focus groups or seven semi‐structured interviews that lasted on average 2 h. Focus and were all conducted the participants' native language, recorded, transcribed (if applicable) translated into English. Thematic analysis was used to develop a codebook identify themes. Results All participants...

10.1111/bju.16635 article EN cc-by-nc-nd BJU International 2025-01-08

317 Background: Early intervention is potentially lifesaving in prostate cancer and a major limitation of outcomes with ethnicity deprivation being determinants inequalities that impact outcomes. The Man Van designed to address health barriers accessing healthcare affect novel community-based targeting high-risk groups using mobile clinical unit. These are particularly relevant for men from ethnic minorities lower socio-economic groups. Methods: A bespoke nurse-led unit was moved locations...

10.1200/jco.2025.43.5_suppl.317 article EN Journal of Clinical Oncology 2025-02-10

ABSTRACT Background Prostate specific antigen density (PSAd) is one of the strongest predictors clinically‐significant prostate cancer (csPCa) in risk calculators. There little evidence on effect volume diagnostic performance PSAd. Our aim was to define accuracy PSAd for predicting csPCa across volumes. Methods 548 patients who underwent magnetic resonance imaging (MRI) and biopsy were included this retrospective study. Patients grouped by volume; small (≤ 30 mL), medium (> < 50 large...

10.1002/pros.24886 article EN The Prostate 2025-03-03

10500 Background: Incidence of prostate cancer (PCa) is increasing, but there no internationally agreed population screening program. Studies using an age-based PSA approach show a high rate false-positive results as well over-diagnosis indolent PCa. Genome wide association studies identify common germline variants to calculate polygenic risk score (PRS) associated with PCa risk. The BARCODE1 study used PRS target those at higher based on genotype. Methods: European men aged 55-69yrs were...

10.1200/jco.2024.42.16_suppl.10500 article EN Journal of Clinical Oncology 2024-06-01

Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of on AS dropout within 5 years, without evidence disease progression. Despite high rates, few have purposively explored opinions and experiences who discontinued AS. The aim this study was gain insight into reasons why some PCa discontinue active progression.Semi-structured interviews were...

10.21037/tau-20-1254 article EN Translational Andrology and Urology 2021-06-01

Aim . To explore patient experiences of a structured exercise intervention for men with prostate cancer (PCa). Sample 41 either localised or advanced PCa who had been referred programme by their physician and then subsequently consented to telephone survey. Method Participants underwent 10-week supervised within large centre hospital consisting 8 sessions. They completed short multiple choice survey, elaborating on responses where appropriate. Views expressed participants were analysed using...

10.1155/2017/3507124 article EN cc-by BioMed Research International 2017-01-01
Srilakshmi Srinivasan Thomas Kryza Nathalie Bock Brian Wan-Chi Tse Kamil A. Sokolowski and 95 more Janaththani Panchadsaram Achala Fernando Leire Moya Carson Stephens Ying Dong Joan Röhl Saeid Alinezhad Ian Vela Joanna Perry‐Keene Katie Buzacott Robert Nica Elizabeth Bancroft Elizabeth Page Audrey Ardern‐Jones Chris Bangma Elena Castro David P. Dearnaley Diana Eccles D. Gareth Evans Jórunn E. Eyfjörd Alison Falconer Christopher S. Foster Freddie C. Hamdy Óskar Þór Jóhannsson Vincent Khoo Geoffrey J. Lindeman Jan Lubiński Lovise Mæhle A. Millner Christos Mikropoulos Anita Mitra Clare Moynihan Judith Offman Gad Rennert Lucy Side Mohnish Suri Penny Wilson Manuela Gago‐Dominguez Pardeep Kumar Antonis C. Antoniou Jana McHugh Holly Ní Raghallaigh R. R. Hall Natalie Taylor Sarah Thomas Kathryn Myhill Matthew Hogben Eva McGrowder Diana Keating Denzil James Jacob Merson Syed Arshad Hussain Angela Wood Nening M. Dennis Paul Ardern-Jones N. van As Steve Hazell Sarah J. Lewis Paul D.P. Pharoah J. Schalken Aslam Sohaib Nandita de Souza Paul Cathcart Frank Chingewundoh Michael C. Perry Jeff Bamber Alexander Dias Christos Mikropolis Sibel Saya Anthony Chamberlain Anne-Marie Borges Da Silva Lucia D’Mello Sue Moss J Melia Netty Kinsella Justyna Sobczak Naami Mcaddy David Nicol Chris Ogden Declan Cahill Alan Thompson Christopher Woodhouse Vincent J. Gnanapragasam Colin Cooper Jeremy Clark Johanna Schleutker Christiane Maier Kenneth Muir Catherine M. Tangen Henrik Grönberg Nora Pashayan Demetrius Albanes Alicja Wolk Janet L. Stanford S.I. Berndt

Abstract Genetic variation at the 19q13.3 KLK locus is linked with prostate cancer susceptibility in men. The non-synonymous KLK3 single nucleotide polymorphism (SNP), rs17632542 (c.536 T > C; Ile163Thr-substitution PSA) associated reduced risk, however, functional relevance unknown. Here, we identify that SNP variant-induced change PSA biochemical activity mediates pathogenesis. ‘Thr’ variant leads to small subcutaneous tumours, supporting risk. However, also displays higher metastatic...

10.1038/s41467-024-52472-6 article EN cc-by Nature Communications 2024-11-06

To determine whether preoperative demonstrations of intracavernosal and vacuum therapies for erectile dysfunction (ED) influence the decision treatment choice, reducing long-term regret.In all, 82 consecutive men with localized prostate cancer, scheduled radical prostatectomy reporting an International Index Erectile Function score >21, were prospectively enrolled at a single cancer centre. Following standard counselling, half invited to attend further consultation therapy demonstrations....

10.1111/j.1464-410x.2011.10237.x article EN BJU International 2011-08-25

We wanted to determine whether serial transperineal sector prostate biopsies have a long-term effect on erectile dysfunction (ED).A total of 64 men with cancer entered our active surveillance (AS) programme after transrectal biopsy as well confirmatory initial (TPSBx).A repeat TPSBx was performed 24 months later part protocol.The International Index Erectile Function-5 (IIEF-5) questionnaire assessed ED at baseline prior each TPSBx, and one, three, six first second TPSBx.There significant...

10.3332/ecancer.2016.643 article EN cc-by ecancermedicalscience 2016-05-23

Objectives: To evaluate how accurate a 12-core transrectal biopsy derived low-risk prostate cancer diagnosis is for an active surveillance programme by comparing the histological outcome with that from confirmatory transperineal sector biopsy. Subjects and methods:The cohort included 166 men diagnosed low volume Gleason score 3+3 on initial who also underwent biopsy.Both techniques were performed according to standard protocols samples taken histopathology analysis.Subgroup analysis was...

10.3332/ecancer.2016.633 article EN cc-by ecancermedicalscience 2016-04-14

6522 Background: Early intervention is potentially lifesaving in prostate cancer. The debate for screening continues with recent developments suggesting the arguments favour are becoming stronger however, barriers to access remain. Man Van project designed address these a highly novel community-based targeting of high-risk groups on mobile unit. Methods: A bespoke health vehicle was moved 8 locations areas high deprivation indices London, UK, inviting men check consisting of: general...

10.1200/jco.2023.41.16_suppl.6522 article EN Journal of Clinical Oncology 2023-06-01
Coming Soon ...